Skip to content

Clinical trials

Terminated Diabetes Mellitus, Type 2 trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Status: Terminated Country / region: United Kingdom Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20044
20055
20063
20074
20093
20122
20131
20141
20163
20174
20181
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca9
Novo Nordisk A/S3
Lexicon Pharmaceuticals2
Novartis Pharmaceuticals2
Takeda2
Barts & The London NHS Trust1
Eli Lilly and Company1
Genmedica Therapeutics S.L.1
GlaxoSmithKline1
Imperial College London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 234
Diabetes Mellitus7
Cardiovascular Diseases3
Heart Failure3
Diabetes Mellitus, Type 12
Hyperglycemia2
Hypertension2
Renal Insufficiency, Chronic2
Asthma1
Chronic Limb-Threatening Ischemia1

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.